The increase in OTC titre in the strain with deleted BGC 42 is highly significant, which raises the question of how a transcriptionally silent BGC, whose corresponding metabolite has not been identified, can influence the biosynthesis of OTC.
← all excerpts
Modulating Complex Secondary Metabolism in <i>Streptomyces rimosus</i> by Targeted Genome Engineering.
1
—
—